The Department of Science and Technology-Philippine Council for Health Research and Development (DOST-PCHRD) said on Monday, May 3, that the clinical trial on the use of Ivermectin as a treatment for coronavirus disease (COVID-19) will involve patients with "non-severe” or those with mild to...